| Scorecard |
|---|
|
4 / 5 Stars
|
|
Lipper
5
5
3
2
4
|
|
Zacks Investment Research
5
(Strong Sell)
|
|
Standard & Poor's
4 / 5 Stars
|
|
TheStreet.com
D+
(Sell)
|
Fund Holdings
Asset Allocation
| % Long | % Net | |
|---|---|---|
| Cash | 2.82 | 2.82 |
| Stocks | 14.78 | 14.78 |
| Bonds | 0.0 | 0.0 |
| Other | 0.0 | 0.0 |
| Foreign Bonds | 0.0 | 0.0 |
| Foreign Stocks | 82.39 | 82.39 |
| Convertible | 0.0 | 0.0 |
| Preferred | 0.01 | 0.01 |
Updated 03.31.2013
Top 10 Holdings
Performance as of 04.30.2013
Portfolio as of 03.31.2013
| Ticker | YTD Return % | % Net Assets | |
|---|---|---|---|
| Nestle SA | NSRGF | 9.65 | 5.05 |
| Anheuser-Busch Inbev SA | AHBIF | 9.81 | 3.45 |
| Novo Nordisk A/S ADR | NVO | 6.86 | 2.36 |
| Linde AG | LIN | --- | 2.28 |
| Roche Holding AG | RHHVF | 23.65 | 2.27 |
| GlaxoSmithKline PLC ADR | GSK | 20.06 | 2.19 |
| Standard Chartered PLC | STAN | --- | 2.16 |
| Denso Corporation | 6902 | --- | 2.05 |
| SABMiller PLC | SAB | --- | 1.98 |
| CSL Limited | CSL | --- | 1.85 |
